TFC Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TFC Therapeutics, Inc. - overview
Established
2022
Location
New York, NY, US
Primary Industry
Biotechnology
About
Founded in 2022 and based in New York, US, TFC Therapeutics, Inc. operates as a biotechnology company that develops novel biologic drugs for the treatment of cancer and to prevent its recurrence. In August 2023, TFC Therapeutics, Inc. raised an undisclosed amount of venture funding led by ARCH Venture Partners, with participation from Alexandria Equities, Alumni Ventures Group, and Breakout Labs.
TFC offers various biologics designed for the treatment of cancer recurrence and metastasis by targeting and eradicating resilient cancer cells responsible for recurrence and metastasis. The company's platform eliminates tumour macrophage hybrid (TMH) cells, which are prevalent in the bloodstream of cancer patients and linked to metastasis, resistance to conventional therapies, relapse, and poor prognosis. The company plans to use the August 2023 funding to develop and commercialize advanced novel technologies and therapeutics for cancer treatment and metastasis prevention.
Current Investors
ARCH Venture Partners, Breakout Ventures, Alumni Ventures Group
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.tfctx.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.